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Tumor and Stem Cell Biology
Reciprocal Metabolic Reprogramming through Lactate
Shuttle Coordinately Inﬂuences Tumor-Stroma Interplay
Tania Fiaschi1, Alberto Marini1, Elisa Giannoni1, Maria Letizia Taddei1, Paolo Gandellini3, Alina De Donatis1,
Michele Lanciotti2, Sergio Serni2, Paolo Cirri1, and Paola Chiarugi1
Abstract
Cancer-associated ﬁbroblasts (CAF) engage in tumor progression by promoting the ability of cancer cells to
undergo epithelial–mesenchymal transition (EMT), and also by enhancing stem cells traits and metastatic
dissemination. Here we show that the reciprocal interplay between CAFs and prostate cancer cells goes beyond
the engagement of EMT to includemutual metabolic reprogramming. Gene expression analysis of CAFs cultured
ex vivo or human prostate ﬁbroblasts obtained from benign prostate hyperplasia revealed that CAFs undergo
Warburg metabolism and mitochondrial oxidative stress. This metabolic reprogramming toward a Warburg
phenotype occurred as a result of contact with prostate cancer cells. Intercellular contact activated the stromal
ﬁbroblasts, triggering increased expression of glucose transporter GLUT1, lactate production, and extrusion of
lactate by de novo expressed monocarboxylate transporter-4 (MCT4). Conversely, prostate cancer cells, upon
contact with CAFs, were reprogrammed toward aerobicmetabolism, with a decrease inGLUT1 expression and an
increase in lactate upload via the lactate transporterMCT1.Metabolic reprogramming of both stromal and cancer
cells was under strict control of the hypoxia-inducible factor 1 (HIF1), which drove redox- and SIRT3-dependent
stabilization of HIF1 in normoxic conditions. Prostate cancer cells gradually became independent of glucose
consumption, while developing a dependence on lactate upload to drive anabolic pathways and thereby cell
growth. In agreement, pharmacologic inhibition ofMCT1-mediated lactate upload dramatically affected prostate
cancer cell survival and tumor outgrowth. Hence, cancer cells allocate Warburg metabolism to their corrupted
CAFs, exploiting their byproducts to grow in a low glucose environment, symbiotically adaptingwith stromal cells
to glucose availability. Cancer Res; 72(19); 5130–40. 2012 AACR.
Introduction
The skill of cancer cells to invade and metastasize is caused
by the genetic changes that these cells have undergone during
multistep tumorigenesis. However, cancer cell microenviron-
ment is a strong determinant of whether or not it acquires the
potential to metastasize (1, 2). Thus, during primary tumor
formation, carcinoma cells engage a multifaceted collection of
cells composed by cancer-associated ﬁbroblasts (CAF), endo-
thelial cells and inﬂammatory cells, the so-called tumor-asso-
ciated stroma, that engage a molecular cross talk with cancer
cells, secreting large amounts of factors/cytokines and inﬂu-
encing invasion and metastasis (3–6).
Cancer cells undergo profound changes in their metabolism
and recently both tumor microenvironment and metabolic
reprogramming have been included in theHallmarks of Cancer
(7). In fact, cancer cells undergo aerobic glycolysis coupledwith
increased glucose uptake caused by incomplete glucose oxi-
dation, that favor cell proliferation through an efﬁcient anab-
olism of glycolytic intermediates, needed to increase cancer
biomass (8, 9). Cancer cells express the M2 splice isoform of
pyruvate kinase (PK), an enzyme that shifts glucose metabo-
lism toward aerobic glycolysis, short-circuiting ATP produc-
tion and avoiding ATP inhibition of glycolysis (10, 11). Hypoxia
has been involved in metabolic reprogramming of cancer cells,
establishing a functional loop between glycolytic and respiring
cells and sustaining survival of cancer cells (12). Indeed,
hypoxia leads cancer cells to upload lactate, produced by
neighboring hypoxic cells, which feeds aerobic cancer cells
through respiration and anabolic functions (12).
A strict link between tumormetabolism and oxidative stress
has also been reported. Indeed, the genetic loss of the NAD-
dependent deacetylase SIRT3 in breast cancers favors the
Warburg phenotype, causing oxidative stress that culminates
in hypoxia-inducible factor-1 (HIF1) stabilization (13). Fur-
thermore, PK-M2 has been indicated as a target of oxidative
stress (14), a very common feature of several cancers. Redox
inhibition of PK-M2 is required to divert glucose ﬂux from
glycolysis to the pentose phosphate pathway, thereby
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generating reducing potential through generation of NADPH
for detoxiﬁcation of reactive oxygen species (ROS; 14–16).
CAFs have already been proven to elicit a prooxidant
environment in cancer cells, deeply affecting tumor progres-
sion and metastasis spread (17). Indeed, CAFs promote epi-
thelial–mesenchymal transition (EMT) in human prostate
carcinoma (PCa) cells as well as enhancement of tumor
growth, increase of stem cell markers development and spon-
taneous metastases (18). The ability of CAFs to elicit EMT and
stem-like traits is because of activation of a proinﬂammatory
signature involving cycloxygenase-2, NF-kB, andHIF1, which is
responsible for a motogen transcriptional program (17). In
addition, CAFs themselves undergo oxidative stress during
their differentiation into a myoﬁbroblast-like highly reactive
and secretory phenotype (19–21).
In this article we report evidence of a reciprocal metabolic
reprogramming of CAFs and PCa cells. In particular, we show
that following activation CAFs shift their metabolism toward a
more glycolytic one, through a HIF1- and oxidative stress-
dependent extrusion of lactate. This catabolite shuttles back to
cancer cells, which use it for tricarboxylic acid cycle and
protein synthesis, fueling cancer cell proliferation.
Materials and Methods
Materials
Unless speciﬁed, all reagents were obtained from Sigma.
Antibodies anti-actin, MCT1, MCT4 were from Santa Cruz
Biotechnology. Antibodies anti-HIF-1a were from Becton
Dickinson. Antibodies anti-SIRT3 were from Cell Signaling.
Antibodies anti-SOD2 and acetyl-lysine were from Abcam.
HIF1-siRNA (sc-35561), MCT1-siRNA (sc-37235), and SIRT3-
siRNA (sc-61555)were fromSanta Cruz Biotechnology. TGF-b1
was from PeproTech. Mitosox and 20,70-dichlorﬂuorescein-
diacetate (DCF-DA) were from Molecular Probe. [U-14C] lac-
tate and [3H]deoxy-glucose were from Perkin Elmer. TaqMan
Reverse Transcription Reagents Kit, Lipofectamine 2000 and
GLUT1 primers were from Invitrogen.
Cell culture
Human PCa cells (PC3) were from the European Collection of
Cell Culture, were authenticated by PCR/short tandem repeat
(STR) analysis (European Collection of Animal Cell Cultures)
and used within 6 months of resuscitation of original cultures.
Healthy human prostate ﬁbroblasts (HPF) and CAFs were
isolated from surgical explanation of patients who signed
informed consent in accordance with the Ethics Committee of
Azienda Ospedaliera Universitaria Careggi. Tissues from
patients affected by benign prostatic hyperplasia or aggressive
PCawere used for obtainingHPFs or CAFs (12). CAFs between 4
and 10passageswere used, tested bymycoplasma presence, and
authenticated by morphology and ﬁbroblast activation protein
expression. Conditioned media (CM) were obtained by 48-hour
serum-starved cells, clariﬁed by centrifugation and used freshly.
Fibroblasts and PCa cells activation
HPFs were grown to subconﬂuence and treated for 24 hours
with CMPCa (obtained culturing PCa cells in serum-free
medium for 48 hours) to obtain PCa-activated ﬁbroblasts (AF).
Fresh serum-freemediumwas added to HPFs for an additional
24 hours before collection of CMHPF.
Western blot analysis
A total of 1  106 cells were lysed for 20 minutes on ice in
500 mL of complete radioimmunoprecipitation assay (RIPA)
lysis buffer (18). Lysates were clariﬁed by centrifugation,
separated by SDS-PAGE and transferred onto polyvinylidene
diﬂuoride. The immunoblots were incubated in 2% milk and
probed with primary and secondary antibodies.
Proliferation assay
PCa cell proliferation has been measured cytometrically
by the use of carboxyﬂuorescein diacetate succinimidyl ester
(CFSE). Cells were treated with 10 mmol/L CSFE for 15
minutes at 37C and then plated alone or in coculture with
CAFs and cultured for 48 hours. Cytoﬂuorimetric analysis
allows the determination of cell proliferation index (the
average number of cell divisions that a cell in the original
population has undergone) on the basis of progressive
decreasing of cell ﬂuorescence as a function of the number
of cell divisions. Alternatively, CAFsþPCa coculture were
grown for 7 days and PCa clones were counted under an
optical microscope.
Real-time PCR
Total RNA (1 mg) was reverse transcribed using TaqMan
Reverse Transcription Reagents Kit. Measurement of gene
expression was performed by quantitative real-time PCR
(RT-PCR; ABI PRISM 7700 Sequence Detector, Applied Biosys-
tems). The amount of target, normalized to an endogenous
reference (eukaryotic 18S RNA, endogenous control, Applied
Biosystem) was given by 2DDCT calculation.
Glucose uptake
Cells were treated with CM for 72 hours. 2-deoxy-glucose
uptake was evaluated in a buffered solution (140mmol/L NaCl,
20 mmol/L Hepes/Na, 2.5 mmol/L MgSO4, 1 mmol/L CaCl2,
and 5 mmol/L KCl, pH7.4) containing 0.5 mCi/mL [3H]deoxy-
glucose for 15minutes at 37C. Cellswere subsequentlywashed
with cold PBS and lysed with 0.1 mol/L NaOH. Incorporated
radioactive was assayed by liquid scintillation counting and
normalized on protein content.
ROS evaluation
For total ROS analysis cells were treated for 3 minute with
5 mmol/L DCF-DA and lysed with RIPA buffer. The ﬂuores-
cence values were normalized for proteins content. Evaluation
ofmitochondrial ROSwas performed adding 5mmol/LMitosox
to the cells for 15 minutes at 37C. After washing the cells with
PBS, ﬂuorescence was analyzed by cytoﬂuorimeter.
Lactate assay
Lactate was measured in the cultured media with Lactate
Assay kit (Source Bioscience Life Sciences) according to the
manufacturer's instruction.
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Incorporation of lactate into proteins
Cells were treated with CM for 72 hours and then [U-14C]
lactate was added for additional 24 hours. Cells were then
resuspended in 20% trichloroacetic acid, placed on ice for 30
minutes and centrifuged. The resuspended pellet was assayed
for [14C] labeled proteins by scintillator.
Detection of released CO2 by radioactive lactate
Cells were treatedwith CM for 72 hours and then 0.2mCi/mL
D-[U-14C] lactate was added for 15 minutes. Each dish had a
taped piece of Whatman paper facing the inside of the dish
wetted with 100 mL of phenyl-ethylamine-methanol (1:1) to
trap the CO2. Then 200 mL of 4M H2SO4 was added to cells.
Finally, Whatman paper was removed, transferred to scintil-
lation vials for counting.
Xenograft experiments
In vivo experiments were conducted in accordance with
national guidelines and approved by the ethical committee of
AnimalWelfare Ofﬁce of ItalianWorkMinistry and conform to
the legal mandates and Italian guidelines for the care and
maintenance of laboratory animals. Experiments were per-
formed using 6- to 8-week-old male severe combined immu-
nodeﬁcient (SCID)-bg/bg mice (Charles River Laboratories
International). Animals (6 per group) were monitored daily
and tumor size was measured every 2 to 3 days by a caliper.
Tumor volumes were determined by the length (L) and the
width (W): V ¼ (LW2)/2 (12).
Statistical analysis
Data are presented as means  SD from at least 3 indepen-
dent experiments. Statistical analysis of the data was per-
formed by Student t test. P values of 0.05 were considered
statistically signiﬁcant.
Results
Analysis of HPFs and CAFs from human patients
In colorectal carcinoma histologic analyses suggest that the
stroma inﬁltrating these tumors buffer and recycle products of
anaerobicmetabolismof cancer cells to sustain invasive cancer
growth (22). On the contrary, in breast cancers PK-M2 and
lactate dehydrogenase (LDH) are highly expressed in the
stromal CAFs (23). In addition, ﬁbroblasts undergoing activa-
tion because of deletion of caveolin-1 experience oxidative
stress, and aHIF1-mediated shift toward aerobic glycolysis and
elimination of mitochondrial activity through mitophagy (24).
In this controversial context we would like to clarify the
contribution of prostate CAFs to Warburg metabolism of
aggressive PCa. Human prostate CAFs were isolated from
prostate biopsies from 9 patients with PCa, whose pathologic
values are reported in Supplementary Table S1. Our choice has
been driven by cancer aggressiveness and prostate-speciﬁc
antigen (PSA) values. As healthy counterparts, we used ﬁbro-
blasts isolated from 4 men with benign prostatic hyperplasia
(HPFs). First, we observed that prostate CAFs undergo
increased anaerobic glycolysis, as revealed by their increased
basal glucose uptake (Fig. 1A). In addition, the analysis of gene
pathways revealed that glycolysis is activated in CAFs with
respect to HPFs, being PK-M2, ALDO-A/B/C, ENO-1/2, TPI-1
the main upregulated genes (Supplementary Fig. 2SA–2SC).
We also observed that CAFs show increased expression of
MCT4 (Fig. 1B), the passive lactate-proton symporter driving
lactate efﬂux, thereby validating the idea that prostate CAFs
increased their lactate production with respect to healthy
HPFs. Finally, we observed that prostate CAFs experience a
state of oxidative stress in comparison to HPFs (Fig. 1C). This
last ﬁnding is in keeping with other data reporting that
oxidants are important players for ﬁbroblast activation and
CAF-dependent tumor invasion (17, 19, 21). Indeed, our data
reveal that both cytoplasmic and mitochondrial H2O2 are
greater in CAFs compared with HPFs (Fig. 1C and D). Gene
expression analysis, glucose uptake, as well as their ROS
production, indicate that prostate CAFs experience aWarburg
metabolism because of their activation in response to cross
talk with cancer cells.
Prostate HPFs undergo Warburg effect in response to
activation
To investigate the activation of Warburg metabolism due to
CAFs differentiation, we used HPFs activated in vitro using CM
from PCa cells. Indeed, we have already reported that PCa
secrete soluble factors able to elicit a mesenchymal–mesen-
chymal transition in HPFs, leading them to an activation state
similar to myoﬁbroblasts (18). We termed these in vitro acti-
vated HPFs, as PCa-AFs. We observed that exposure of HPFs to
PCa-CM elicits a clear increase in their lactate secretion (Fig.
2A), likely because of the increase inMCT4 in PCa-AFs (Fig. 2B).
Activation of ﬁbroblasts does not affect their usage of lactate,
as revealed by analyses of lactate upload andMCT1 expression
level (Fig. 2B and Supplementary Fig. S3). A conversion to a
Warburg metabolism in response to ﬁbroblast activation is
conﬁrmed by the ability to increase the expression of GLUT1
glucose transporter and the consequent enhanced glucose
uptake (Fig. 2C and D).
The Warburg metabolic shift in CAFs is redox and HIF1
dependent
Differentiation of CAFs toward a myoﬁbroblast phenotype
has been reported as a redox-dependent event (19, 21). In
addition, HIF1 is a master regulator of anaerobic metabolism
during exposure to hypoxia, which undergoes redox regulation
as well. To address the possibility that the conversion to a
Warburg phenotype of HPFs could be dependent on oxidative
stress and HIF1-mediated transcription in normoxia, we ﬁrst
observed that PCa-AFs have a higher basal level of ROS with
respect to HPFs (Fig. 3A). Pretreatment of HPFs and PCa-AFs
with the oxidant scavenger N-acetyl cysteine (NAC) inhibits
lactate extrusion by ﬁbroblasts (Fig. 3B), suggesting that their
Warburg phenotype depends on ROS content. In agreement,
we found that the expression of the MCT4 transporter is
decreased in presence of the scavenger (Fig. 3C). Although
HPFs are activated to PCa-AFs in normoxia, we observed a
clear stabilization of the transcription factor HIF1 in PCa-AFs,
in agreement with their high-ROS content (Fig. 3C). The
inhibition of HIF1, either transcriptionally by RNA interference
Fiaschi et al.
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or functionally with the inhibitor topotecan, conﬁrms that
HIF1 plays amandatory role in bothMCT4 upregulation due to
ﬁbroblast activation and in lactate efﬂux (Fig. 3B–D).
SIRT3 is involved in ROS production and HIF1
stabilization in PCa-AFs
Recent evidence showed that the mitochondrial deacetylase
SIRT3 is involved in the control of HIF1 expression, and redox
signaling has been implicated in such control (13). A decrease
in SIRT3 expression leads to increased superoxide dismutase 2
(SOD2) acetylation/inhibition, thereby causing ROS increase
and HIF1 stabilization (25, 26). We observed that the contact
with PCa cells, while activating HPFs to PCa-AFs, leads in
ﬁbroblasts to a downregulation of SIRT3 and an increase in
SOD2 acetylation, together with a clear stabilization of HIF1
(Fig. 4A). In agreement with the idea of a redox-mediated
stabilization of HIF1 via SIRT3 dowregulation, mitochondrial
ROS are strongly increased upon HPFs activation (Fig. 4B and
C). SIRT3 acts as a key upstream regulator of ROS production
during HPFs activation, leading to HIF1 stabilization. Indeed,
when downregulation of SIRT3was forced by RNA interference
in HPFs, we found a strong overproduction of ROS accompa-
nied by a dramatic increase of HIF1 accumulation (Fig. 4D).
The role of SIRT3 is also conﬁrmed by treatmentwith the SIRT-
activator kaempferol, leading to ROS andHIF1 downregulation
in CAFs (Fig. 4C).
PCa upload lactate produced by CAFs
Because HPFs undergoWarburg effect upon their activation
in response to PCa interplay, extruding lactate in the extra-
cellular compartment, we speculate that PCa cells can upload
this lactate generated by stromal ﬁbroblasts, using it for
different purposes. To address this point PCa cells were treated
with CM from HPFs or CAFs (ex vivo cultures), or cocultured
with HPFs (obtaining PCa-AFs). On the basis of data obtained
by our analysis of ex vivo ﬁbroblasts (Fig. 1), we used for further
studies HPFs 1, 3, and 4 or CAFs 1, 4, and 9. The results show
that lactate produced by CAFs is strongly decreased where PCa
are present (both treatment with CM or coculture), thus
suggesting that lactate has been consumed by PCa (Fig. 5A).
Because activated ﬁbroblasts showed unchanged MCT1
expression and unaffected lactate upload compared with HPFs
(Fig. 2B and Supplementary Fig. S1), we speculated that PCa in
contact with CAFs are also metabolically reprogrammed to
upload lactate. In keeping, we found that theMCT1 transporter
is upregulated in PCa cells treated with CM from CAFs or in
coculture with CAFs (Fig. 5B). In agreement, MCT4 expression
in PCa cells is unaffected by coculture with CAFs (Supplemen-
tary Fig. S4A). Again, HIF1 and redox signaling play a
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mandatory role in metabolic reprogramming of PCa cells
through upregulation of MCT1, as revealed by treatments with
NAC or topotecan (Fig. 5B).
To analyze the destiny of lactate extruded by CAFs, we treated
PCa cells with [14C]-lactate and analyzed its upload by PCa cells,
after treatment with CM or coculture with CAFs (Fig. 5C, top
panel). In the same experimental setting, we also evaluated re-
spiration of lactate by PCa, through analysis of released [14C]-CO2,
and lactate reconversion toward anabolic pathways, through
analysis of [14C]-proteins (Fig. 5C, middle and bottom panels).
The results clearly indicate that both CM or direct contact with
CAFs, drive ametabolic reprogramming of PCa cells leading them
to upload lactate and to use it both in respiration and anabolism.
Final conﬁrmation of a metabolic shift of PCa cells toward an
aerobic metabolism, upon contact with CAFs, is given by analyses
of both [3H]-glucose uptake and expression of GLUT1 (Fig 5D).
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Lactate shuttle is functional for PCa cell growth
With the aim to investigate what is the beneﬁt for PCa cells
to upload lactate produced by surrounding CAFs, we ﬁrst
analyzed cell proliferation. PCa cells were labeled with the
ﬂuorochrome CSFE, cocultured with CAFs and then assayed
for proliferation by ﬂow cytometry. The results indicate that
the proliferation index of PCa cells increased by 30%, suggest-
ing an active role of CAFs in sustaining PCa cells proliferation
(Fig. 6A). The relevance of lactate upload for PCa cell growth
was conﬁrmed using a-cyano-4-hydroxycinnamate (CHC), a
speciﬁc MCT1 inhibitor, already acknowledged to disrupt
lactate shuttle between hypoxic and normoxic cells within
tumors (refs. 12, 27; Fig. 6A). Furthermore, PCa cell growth was
assayed in a time course coculture experiment, inwhich cancer
cells were seeded with increasing number of CAFs (1:3; 1:5;
1:10). PCa islets developed after some days and we observed a
clear trophic effect of CAFs for PCa cell proliferation (Fig. 6B).
Again, the advantage given by coculture with CAFs for PCa cell
growth was reverted by blocking the function of MCT1 trans-
porter with CHC (Fig. 6B). The effect of CHC is highly speciﬁc
for PCa cells, which are actively uploading lactate, as it
impairs the viability of PCa cells without signiﬁcantly affect-
ing CAFs viability (Fig. 6C). Similar results were observed
after silencing of MCT1 by RNA interference (Supplementary
Fig. S4B) or by the use of different metabolism inhibitors.
Indeed, the block of the metabolic circuitry established
between cocultured PCa cells and CAFs, by treatment with
2-deoxyglucose (2-DG), dichloroacetate (DCA), or Antimycin
A, as well as forced reexpression of SIRT3 by kaempferol (28),
leads to a remarkable decrease of PCa cell growth (Fig. 6D).
We ﬁnally validated in vivo the idea that CAFs induce a
metabolic shift in neighboring PCa cells, leading them to
become MCT1-dependent for their growth. Wild type or
MCT1 silenced PCa were subcutaneously injected in SCID-
bg/bg together with CAFs. As we already reported, coinjec-
tion of CAFs with PCa cells strongly enhances the tumor
growth rate (17), although we observed that silencing of
MCT1 reduces this ability by 50%, thereby underscoring the
Figure 4. HIF1 accumulation is
regulated by SIRT3 in PCa-AFs.
HPFswere treatedwithCMPCa for 24
hours obtaining PCa-AFs, then
serum-free medium was added for
an additional 48 hours. A,
immunoblot analysis of HIF1, SIRT3,
SOD2, and acetyl-SOD2. Actin
immunoblot was used for
normalization. B, cytoﬂuorimetric
analysis of mitochondrial ROS using
Mitosox probe. C, immunoblots for
SIRT3, HIF1, and CAIX (a common
target of HIF1) were done on CAFsþ
PCa coculture. Note that 25 mmol/L
and 50 mmol/L kaempferol (SIRT3
activator) was added to serum-free
medium for 24 hours. Actin
immunoblot was used for
normalization. Total ROS production
of the same samples is reported in
the plot below. D, SIRT3 was
silenced in HPFs by RNA
interference for 48 hours before
adding CMPCa. HIF1 and SIRT3
immunoblots are shown and total
ROS production of the same
samples is reported in the plot
below. , P < 0.001 versus HPFs;
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signiﬁcance of lactate shuttle between CAFs and PCa cells
during tumor growth (Fig. 6E).
Discussion
The emergence of new antineoplastic drugs targeting met-
abolic pathways urgently prompt the scientiﬁc community to
study metabolic deregulation of tumors, to clarify the differ-
ences among different tumor histotypes, as well as of the
stromal cells inﬁltrating growing tumors. Conﬂicting data are
emerging about the role of stromal ﬁbroblasts in metabolic
reprogramming of cancer cells. Histopathologic analysis
reveals that PK-M2 and LDHare highly expressed in the stroma
of breast cancer lacking caveolin-1 expression (23). In addition,
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ﬁbroblasts undergoing activation because of caveolin-1 dele-
tion, or in response to downregulation of caveolin-1 upon
oxidative stress induced by contact with cancer cells, show
a stabilization of HIF1 (23, 29, 30). Although these ﬁbroblasts
are not properly ex vivo CAFs, they experience a shift toward
aerobic glycolysis and elimination of mitochondrial activity
through mitophagy (30). In disagreement with these data,
histologic analyses of colorectal carcinoma suggested that the
stroma inﬁltrating these tumors expresses aerobicmetabolism
enzymes that are involved in recycling products of anaerobic
metabolism of cancer cells to sustain invasive cancer growth.
In keeping, a very recent study reported that hypoxic breast
cancer cells recruit mesenchymal stem cells through their
secretion of lactate due to glycolytic Warburg metabolism,
allowing stromal cells to use lactate produced by tumor cells
(31).
On the basis of these controversial ﬁndings, our investiga-
tions focused on ex vivo CAFs, obtained by patients bearing
cancers with clear aggressiveness as revealed by their grading
andPSA values, are therefore really warranted. In ourmodel we
observed that CAFs behave asmetabolic synergistic bystanders
of cancer cells, actively participating in the complex metabo-
lism of tumors, by engaging a biunivocal relationship with
cancer cells forcing them to respire and overcome energy
depletion because of theWarburg effect (Fig. 7A). In particular,
ﬁbroblasts in contact with epithelial cancer cells undergo
myoﬁbroblast differentiation and produce lactate through
aerobic glycolysis and Warburg metabolism (Fig. 7B), which
is used by cancer cells for respiration. In addition, cancer cells
lactate uptake leads to the reduction of extracellular acidity,
which represents an unfavorable environmental factor for
tumor survival. The metabolic reprogramming of PCa cells
and their CAFs involves also reexpression of MCT4 in CAFs,
granting for efﬁcient extrusion of lactate fromCAFs, andMCT1
in cancer cells, allowing them to powerfully upload the ana-
bolite to respire and fuel anabolism. Expression of MCT4 is
increased in CAFs extracted by human PCa, compared with
benign prostate hyperplasia, with higher MCT4 level associ-
ated with poorer clinical outcome. In keeping with these data,
stromal MCT4 has been correlated with poor clinical outcome
in triple-negative breast cancers (32). The upload of lactate by
opportunistic cells has been described in other symbiotic
systems (33–36). Hypoxic and normoxic areas of tumors are
able to engage a sort of Cori Cycle culminating in fueling
respiration of normoxic cells with lactate at expenses of the
anaerobic metabolism of hypoxic cells (12). In addition, MCT1
expression and lactate upload has been correlated with p53
loss, with higher MCT1 expressed by tumors associated with
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poorer clinical outcome (37). In keeping with these data, we
show here that MCT1 expression by PCa is mandatory for
tumor outgrowth, as indicated by the efﬁciency of in vivo
targeting of MCT1 with CHC or RNA interference.
MCT1 expression due to p53 loss is correlated with exposure
to hypoxia of breast cancer cells (37). We observed that
exposure of PCa cells to CAFs does not need hypoxia to elicit
MCT1 expression and functional lactate dependence of cell
Figure 7. Proposed model of the metabolic loop between CAFs and PCa. A, CAFs and PCa cells establish reciprocal metabolic changes. PCa cells
favor in CAFs, a Warburg-like glycolytic metabolism, thus increasing glucose uptake and its conversion into lactate. Lactate extruded by CAFs by MCT4
transporter is uploaded by PCa cells, through their MCT1 transporter, and used for fueling Krebs cycle, as well as anabolic processes and cell proliferation. B,
network of molecules involved in lactate metabolism in CAFs. An in silico search for connections between genes modulated in prostatic CAFs and
involved in lactate metabolism was accomplished using Ingenuity Pathway Analysis Spring Release 2012 (Ingenuity Systems; www.ingenuity.com). The
network was grown starting from molecules that were upregulated in CAFs versus HPFs on the basis of our unpublished microarray analysis and
related to the catabolism of carbohydrates. Overall, scales of pink indicate upmodulated genes, whereas scales of green are used for downmodulated genes.
Additional molecules recognized as relevant for lactate metabolism from our experiments were included and colored in red when upregulated or dark green
when downregulated at protein level. Direct or indirect interactions betweenmolecules are indicatedwith either a solid or a dashed line, respectively, andmay
consist of activation (!), inhibition (—j), or binding (—). Molecular functions (Fx) and canonical pathways (CP) were ﬁnally added to the drawing.
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survival/growth, as well as of tumor outgrowth in SCID mice.
These data are in agreement with our previous observations
indicating that CAFs are able to mimic hypoxic signaling in
PCa cells, inducing HIF1 activation through oxidative stress-
mediated stabilization of the transcription factor (18, 38, 39).
We now enlarge the value of oxidative stress-mediated HIF1
signaling in tumor microenvironment, as the metabolic repro-
gramming toward glycolisis of CAFs and toward reverse War-
burg metabolism of PCa cells are both redox-dependent.
Hence, CAFs and hypoxia are synergistic mediators of tumor
microenvironment, both exploiting oxidative stress to signal
downstream through HIF1 transcription, to enhance tumor
cell plasticity affecting both motility (36) and metabolism
(38, 40). In keeping, we show here that oxidative stress in CAFs
explanted from tumors correlatedwith PCa aggressiveness and
PSA values.
Oxidative stress and redox-mediatedHIF1 stabilization have
also been involved in SIRT3 loss and consequent deregulation
of oxidative pathways (25, 41). In particular, SIRT3 opposes to
Warburg phenotype of cancer cells, mainly acting via desta-
bilization of HIF1, leading to inhibition of glycolysis and
activation of oxidative metabolism (13). We now report that
the NAD-dependent deacetylase SIRT3 is clearly downregu-
lated during stromal reactivity and myoﬁbroblasts differenti-
ation, thereby leading to SOD acetylation/activation and driv-
ing a ROS-dependent HIF1 stabilization. The glycolytic switch
evident in breast cancer cells lacking SIRT3 has been proposed
to contribute to tumorigenesis (13), but we now enlarge the
role played by SIRT3 loss or loss of function by including CAFs
as cells undergoing a SIRT3-mediated regulation of HIF1 and
Warburg metabolism.
CAFs have already been acknowledged to elicit epigenetic
programs leading cancer cells to achieve stem-like features and
mesenchymalmotility through EMT (18). Both these events are
driven by HIF1- and NF-kB-dependent proinﬂammatory sig-
nature, exploiting oxidative stress (17). Now, among CAFs
duties, we include metabolic reprogramming of cancer cells
toward a reverse Warburg phenotype, allowing carcinoma
highly inﬁltrated by reactive stroma to allocate Warburg
metabolism to stromal cells and exploiting their byproducts
to survive and grow in a glucose-free milieu. This feature is
again an example of adaptive strategies engaged by plastic
cancer cells, as these cells can either use Warburg metabolism
in high glucose environment, but shift to reverse Warburg
metabolism upon CAFs contact, if hypoxic/ischemic condi-
tions lead to glucose starvation.
These data have important pharmacologic implications, as
they include stromal ﬁbroblasts as key regulators of metabolic
adaptive strategies based on oxidative stress handling, engaged
by cancer cells to face the hostile tumor environment, adding a
further level of complexity to the system. Problems handling in
vivo drugs targeting Warburg metabolism, such as DCA or 2-
DG, could rely on the multiple adaptations exploited by cancer
cells, due or in synergy with its stroma. Indeed, targeting of
glycolysis is largely insufﬁcient to inhibit progression toward
aggressive behavior, as malignant cells exploit oxidative stress
to engage antioxidant responses, involving Nrf-2 transcription
(42) and activation of pentose phosphate pathway (15, 43–46).
Hence, possible successful anticancer therapies should target
both management of oxidative stress and metabolic Warburg
reprogramming, addressing both glycolysis and penthose
phosphate pathway, in both cancer and stromal cells, thus
impairing the ability of cancer cells to exploit oxidative stress
but forcing them to succumb to it.
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